Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Mike who wrote (2071)	5/30/2003 4:39:44 AM
From: Crossy	Respond to of 23958

Mike, sorry not my type of company. It got a BILLION market cap and it's multiples aren'T cheap. I have a problem with research oriented biotech / pharma cos. because I'm not a chemist or pharmacologist to value the future payoffs from their drug pipeline. That's why I like generics way more. Also, I like smaller cap biotechs better with marketcaps under $200m. From valuation measures, PBK, PSR - MDCO is not cheap. I rose tremdendously already. My style is getting in CHEAP and not when the stock went up 5 times from where one could have bought it... And I always invest my own money- not like those people in Japan 10 years ago where the bank compensated for losses <g> nice offer but I got to decline.. anyway I hope it will be a profitable investment for you.. rgrds CROSSY